(Total Views: 222)
Posted On: 09/17/2019 9:25:46 AM
Post# of 36549
$GNBT News Article - Generex Biotechnology Announces First Patient Enrolled in the Phase II Clinical Trial of AE37 in Combination with Pembrolizumab (Keytruda ) for the Treatment of Triple Negative Breast Cancer https://marketwirenews.com/news-releases/gene...76013.html
(1)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
